Adenovirus Production In Single-Use ReadyToProcess WAVE™ 25 Bioreactor System
Source: Cytiva

Upstream virus production for vaccine manufacturing is typically performed in stirred-tank bioreactor systems, but rocking bioreactor systems offer the benefits of low minimum working volumes that can shorten the seed train prior to inoculation, and agitation can be adjusted to a smooth rocking motion for optimized growth of sensitive cells. This application note describes the production of adenovirus in HEK293 suspension cells in a rocking bioreactor. Triplicate cultures demonstrate a reproducible and robust batch production of adenovirus.
VIEW THE APPLICATION NOTE!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of BioProcess Online? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
This website uses cookies to ensure you get the best experience on our website. Learn more